Facebook
Twitter
LinkedIn
ForwardTexas Transplantation Society Annual Scientific Meeting (JS1907B)
Organ Transplantation is a rapidly expanding field with constant changes and innovations aimed at best serving our ever-expanding patient population. Innovation and change while exciting and beneficial to our patients present challenges can be difficult to keep up with in the field as a whole. Two Keynote Lectures from national leaders will be given on topics at the forefront of our field. These include Xenotransplantation and Vascularized Composite Allotransplantation. The rest of the expert speakers will address topics in several different areas of organ transplantation as well as updates on the global changes in transplantation that were introduced in the 2018 meeting which will allow us to evaluate the outcomes of these changes and ensure that changes and innovations are best serving our transplant patients.
Target Audience
This conference is designed for physicians, surgeons, scientists, registered nurses, transplant and procurement coordinators, HLA lab directors and staff, social workers, transplant administrators, and others involved in solid organ and bone marrow donation, procurement, and transplantation.
Learning Objectives
- Discuss and evaluate current practices, future innovations and research in the areas of Xenotransplantation and VCA in order to expand these investigations and practices to other transplant centers or to understand current and future options for patients all over the United States.
- Identify and discuss the indications for using the normothermic perfusion systems for donor lungs, liver and hearts.
- Interpret the technical aspects of placing an organ on the OCS system
- Describe the functionality and how to interpret the clinical information provided by OCS systems
- Evaluate the clinical outcomes of the patients who received organs that were placed on the OCS system.
- Assess the implications and outcomes of using Hep C and HIV+ organ donors.
- Evaluate the implications and outcomes of peri-transplant obesity surgery.
- Discuss the implications of Marijuana use in Transplant Recipients especially in the era of Marijuana legalization
Tiffany Anthony, MD-Transplant Surgeon
Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB)
Scott Bennett
Jose Castillo-Lugo, Medical Director Kidney Pancreas Transplant Program Methodist Dallas Medical Center
Yvette Chapman, RN, BSN, CCTC
Carie Kadric, RN, BSHCA
Malcolm MacConmara, MB BCh., FACS
David Mason, MD
Alejandro Mejia
Matthias Peltz, MD
Elizabeth Thomas
Parsia Vagefi
Tiffany Anthony, MD-Transplant Surgeon
Tiffany Anthony, MD-Transplant Surgeon
Tiffany Anthony, MD-Transplant Surgeon
Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB)
Scott Bennett
Jose Castillo-Lugo, Medical Director Kidney Pancreas Transplant Program Methodist Dallas Medical Center
Yvette Chapman, RN, BSN, CCTC
Carie Kadric, RN, BSHCA
Malcolm MacConmara, MB BCh., FACS
David Mason, MD
Alejandro Mejia
Matthias Peltz, MD
Elizabeth Thomas
Parsia Vagefi
Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB)
Benjamin Aussi, BSN, RN, MBA
David Cooper, MA, PhD, MD, MS, DSc(Med), FRCS, FACS, FACC, FAST
Ryan Davies, MD
Richard Dickerman, Medical Director
Susan Fogus, RN, BSN
Juan Guerrero, MD
Carie Kadric, RN, BSHCA
Tarunjeet Klair, M.D.
W P Andrew Lee, EVP Academic Affairs, Provost and Dean, UT Southwestern Medical School
KENNETH LIAO, MD, PhD
Gabriel Loor
Malcolm MacConmara, MB BCh., FACS
Greg McKenna, M.D. , F.R.C.S.(C) , F.A.C.S
Cathi Murphey, PhD
Joe Nespral
Javier Nieto, MD, CPTC
Jeffrey Orlowski, MS, CPTC
Donna Smith, Donna Smith, Vice President Organ Operations at LifeGift
CEDRIC SPAK, Transplant Infectious Disease Specialist
James Trotter
Parsia Vagefi
Gerald Winder, MD MSc
David Wojciechowski, DO
ACCREDITATION AND CREDIT DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Texas Southwestern Medical Center and Texas Transplantation Society. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 12.5 AMA PRA Category 1 Credits™.
Available Credit
- 12.50 AMA
- 12.50 Attendance
Price
Certificate
select the "Take Course" button to complete the course evaluation and to retrieve your certificate.
If you do not see the "Take Course" button, login to your EthosCE account or create an account using the email address used during the course registration or signin*. A profile can be created at the following link:
https://cme.utsouthwestern.edu/user/register
In order to access the course to retrieve a CME certificate the email provided at sign-in* must match the email in your EthosCE profile. If you provided an email different from your EthosCE profile please contact the CME office at cmeregistrations@utsouthwestern.edu. If you have not already created a profile in EthosCE, please create one using the same email provided during the course registration or signin*.
*Course administrators may have retrieved the email address from the course registration, the organization directory or during the course sign-in.